Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment

doi:10.1038/s41591-021-01320-x

Comment

. 2021 Apr;27(4):586-588.

doi: 10.1038/s41591-021-01320-x.

Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment

Tian Zhang^{1

2}, Daniel J George^{3

4}

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Durham, NC, USA. tian.zhang2@duke.edu.
² Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC, USA. tian.zhang2@duke.edu.
³ Division of Medical Oncology, Department of Medicine, Durham, NC, USA.
⁴ Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC, USA.

PMID: 33820997
DOI: 10.1038/s41591-021-01320-x

Comment

Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment

Tian Zhang et al. Nat Med. 2021 Apr.

. 2021 Apr;27(4):586-588.

doi: 10.1038/s41591-021-01320-x.

Authors

Tian Zhang^{1

2}, Daniel J George^{3

4}

Affiliations

¹ Division of Medical Oncology, Department of Medicine, Durham, NC, USA. tian.zhang2@duke.edu.
² Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC, USA. tian.zhang2@duke.edu.
³ Division of Medical Oncology, Department of Medicine, Durham, NC, USA.
⁴ Duke Cancer Institute Center for Prostate & Urologic Cancers, Durham, NC, USA.

PMID: 33820997
DOI: 10.1038/s41591-021-01320-x

No abstract available

PubMed Disclaimer

Comment on

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.
Motzer R, Alekseev B, Rha SY, Porta C, Eto M, Powles T, Grünwald V, Hutson TE, Kopyltsov E, Méndez-Vidal MJ, Kozlov V, Alyasova A, Hong SH, Kapoor A, Alonso Gordoa T, Merchan JR, Winquist E, Maroto P, Goh JC, Kim M, Gurney H, Patel V, Peer A, Procopio G, Takagi T, Melichar B, Rolland F, De Giorgi U, Wong S, Bedke J, Schmidinger M, Dutcus CE, Smith AD, Dutta L, Mody K, Perini RF, Xing D, Choueiri TK; CLEAR Trial Investigators. Motzer R, et al. N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13. N Engl J Med. 2021. PMID: 33616314 Clinical Trial.

Cited by

Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma.
Zhou H, He Y, Huang Y, Li R, Zhang H, Xia X, Xiong H. Zhou H, et al. Front Cell Dev Biol. 2023 Apr 3;11:1157269. doi: 10.3389/fcell.2023.1157269. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37077419 Free PMC article.
Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S, Hou Y, Hu M, Hu J, Liu X. Huang S, et al. BMC Cancer. 2022 Sep 19;22(1):995. doi: 10.1186/s12885-022-10087-4. BMC Cancer. 2022. PMID: 36123627 Free PMC article.
Multiregional Sequencing Analysis Reveals Extensive Genetic Heterogeneity in Gastric Tumors from Latinos.
Toal TW, Estrada-Florez AP, Polanco-Echeverry GM, Sahasrabudhe RM, Lott PC, Suarez-Olaya JJ, Guevara-Tique AA, Rocha S, Morales-Arana A, Castro-Valencia F, Urayama S, Kirane A, Wei D, Rios-Sarabia N, Medrano R, Mantilla A, Echeverry de Polanco M, Torres J, Bohorquez-Lozano ME, Carvajal-Carmona LG. Toal TW, et al. Cancer Res Commun. 2022 Nov 28;2(11):1487-1496. doi: 10.1158/2767-9764.CRC-22-0149. eCollection 2022 Nov. Cancer Res Commun. 2022. PMID: 36970058 Free PMC article.
Immunotherapeutic Innovations in Clear Cell Renal Cell Carcinoma: Current Strategies and Future Directions.
Chipuc S, Bogdan H, Serban D, Badiu DC, Zgura A, Anghel R. Chipuc S, et al. Cancer Diagn Progn. 2024 Sep 1;4(5):558-562. doi: 10.21873/cdp.10363. eCollection 2024 Sep-Oct. Cancer Diagn Progn. 2024. PMID: 39238630 Free PMC article. Review.
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma.
Wu S, Wang B, Li H, Wang H, Du S, Huang X, Fan Y, Gao Y, Gu L, Huang Q, Chen J, Zhang X, Huang Y, Ma X. Wu S, et al. Oncogene. 2024 May;43(20):1534-1548. doi: 10.1038/s41388-024-03013-4. Epub 2024 Mar 28. Oncogene. 2024. Retraction in: Oncogene. 2025 Aug 8. doi: 10.1038/s41388-025-03526-6. PMID: 38548966 Retracted.

See all "Cited by" articles

References

1. Motzer, R.J. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2035716 (2021).
1. Choueiri, T. K. & Motzer, R. J. N. Engl. J. Med. 376, 354–366 (2017). - DOI
1. Motzer, R. J. et al. N. Engl. J. Med. 369, 722–731 (2013). - DOI
1. Chen, D. S. & Mellman, I. Nature 541, 321–330 (2017). - DOI
1. Albiges, L. et al. ESMO Open 5, e001079 (2020). - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Motzer, R.J. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2035716 (2021).

[2] Motzer, R.J. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2035716 (2021).

[3] Choueiri, T. K. & Motzer, R. J. N. Engl. J. Med. 376, 354–366 (2017). - DOI

[4] Choueiri, T. K. & Motzer, R. J. N. Engl. J. Med. 376, 354–366 (2017). - DOI

[5] Motzer, R. J. et al. N. Engl. J. Med. 369, 722–731 (2013). - DOI

[6] Motzer, R. J. et al. N. Engl. J. Med. 369, 722–731 (2013). - DOI

[7] Chen, D. S. & Mellman, I. Nature 541, 321–330 (2017). - DOI

[8] Chen, D. S. & Mellman, I. Nature 541, 321–330 (2017). - DOI

[9] Albiges, L. et al. ESMO Open 5, e001079 (2020). - DOI

[10] Albiges, L. et al. ESMO Open 5, e001079 (2020). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment

Affiliations

Immunotherapy and targeted-therapy combinations mark a new era of kidney cancer treatment

Authors

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical